Switzerland's Siegfried Group, a specialist in active
pharmaceutical ingredients (APIs), dosage forms and
biopharmaceuticals, has boosted its position in the production of
controlled substances with the acquisition of US-based...
Italy's fine chemicals industry organisation, Afaquim, is
organising a conference in September aimed at coordinating the
efforts of European active pharmaceutical ingredient (API)
suppliers in the face of increasing competition...
Lonza is planning a major exansion of its peptides manufacturing
capacities at Visp, Switzerland, in response to what it said was
'the increased demand for peptide active pharmaceutical ingredients
The fine chemicals business unit of Lanxess, which was spun-out
from Germany's Bayer earlier this year and provides custom
manufacturing services to the pharmaceutical and other industries,
has said it plans to expand its geographic...
Schweizerhall is well on the way to completing its acquisition of
Cimex Pharma, and as a result completing the first stage of its
transition to become a specialist supplier to the European generics
industry, reports Phil Taylor.